 | • レポートコード：MRC22NVL19264 • 出版社/出版日：LP Information / 2022年10月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥541,680 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,083,360 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界経済が回復するにつれて、2021年の鼻腔内薬物送達技術の成長は前年から大幅に変化します。LP Information社（米国）の最新の調査によると、世界の鼻腔内薬物送達技術市場規模は、2021年の000ドルから2022年には000ドルに達し、2021年～2022年間に000%の成長が予想されます。2028年には世界の鼻腔内薬物送達技術市場規模が000ドルまで成長し、調査期間中に000%の年平均成長率を記録すると予想されます。 米国の鼻腔内薬物送達技術市場は2021年に000ドルの市場規模が見込まれ、調査期間中は約000%の年平均成長率で成長すると予測されます。中国は世界の鼻腔内薬物送達技術市場の000%のシェアを占め、2028年までに000ドルに達すると展望されます。欧州の鼻腔内薬物送達技術の状況については、ドイツが2028年までに000ドルに達し、調査期間にわたって年平均成長率が000%になると予測されます。アジア地域では、日本と韓国の成長率が、今後5年間でそれぞれ000%と000%になると展望されます。 世界の主要な鼻腔内薬物送達技術プレーヤーとして、3M United States、 Aegis Therapeutics LLC、 Aptargroup, Inc.、 Becton, Dickinson and Company、 BF Ascher & Company, Inc.、 Cadila Pharmaceuticals Ltd、 Dickinson and Company、 Douglas Pharmaceuticals Ltd、 ENT Technologies Pty. Ltd、 Glaxosmithkline PLC、 Johnson & Johnson、 Merck & Co., Inc.、 Novartis AG、 OptiNose, Inc、 PendoPharm, Inc、 Pfizer,などをカバーしています。売上の面では、世界のトップ2社が2021年に約000%市場シェアを占めています。 当レポートでは、製品タイプ、用途（アプリケーション）、主要メーカー、主要地域および国ごとの鼻腔内薬物送達技術市場の包括的な概要、市場シェア、および成長機会を掲載します。 タイプ別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ 加圧式、無加圧式 用途（アプリケーション）別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ 鼻づまり、鼻炎、喘息、その他 当レポートは次の地域と国の市場規模データを掲載します。 南北アメリカ（米国、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東/アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：鼻腔内薬物送達技術の年間販売量2017-2028、地域別現状・将来分析 ・鼻腔内薬物送達技術のタイプ別セグメント：加圧式、無加圧式 ・鼻腔内薬物送達技術のタイプ別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 ・鼻腔内薬物送達技術の用途別セグメント：鼻づまり、鼻炎、喘息、その他 ・鼻腔内薬物送達技術の用途別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 企業別世界の鼻腔内薬物送達技術市場 ・企業別のグローバル鼻腔内薬物送達技術市場データ：2020-2022年の年間販売量、市場シェア ・企業別の鼻腔内薬物送達技術の年間売上：2020-2022年の売上、市場シェア ・企業別の鼻腔内薬物送達技術販売価格 ・主要企業の鼻腔内薬物送達技術生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 鼻腔内薬物送達技術の地域別レビュー ・地域別の鼻腔内薬物送達技術市場規模2017-2022：年間販売量、売上 ・主要国別の鼻腔内薬物送達技術市場規模2017-2022：年間販売量、売上 ・南北アメリカの鼻腔内薬物送達技術販売の成長 ・アジア太平洋の鼻腔内薬物送達技術販売の成長 ・欧州の鼻腔内薬物送達技術販売の成長 ・中東・アフリカの鼻腔内薬物送達技術販売の成長 南北アメリカ市場 ・南北アメリカの国別の鼻腔内薬物送達技術販売量、売上（2017-2022） ・南北アメリカの鼻腔内薬物送達技術の種類別販売量 ・南北アメリカの鼻腔内薬物送達技術の用途別販売量 ・米国の鼻腔内薬物送達技術市場 ・カナダの鼻腔内薬物送達技術市場 ・メキシコの鼻腔内薬物送達技術市場 ・ブラジルの鼻腔内薬物送達技術市場 アジア太平洋市場 ・アジア太平洋の国別の鼻腔内薬物送達技術販売量、売上（2017-2022） ・アジア太平洋の鼻腔内薬物送達技術の種類別販売量 ・アジア太平洋の鼻腔内薬物送達技術の用途別販売量 ・中国市場の鼻腔内薬物送達技術市場 ・日本市場の鼻腔内薬物送達技術市場 ・韓国市場の鼻腔内薬物送達技術市場 ・東南アジアの鼻腔内薬物送達技術市場 ・インドの鼻腔内薬物送達技術市場 ・オーストラリアの鼻腔内薬物送達技術市場 ・台湾の鼻腔内薬物送達技術市場 欧州市場 ・欧州の国別の鼻腔内薬物送達技術販売量、売上（2017-2022） ・欧州の鼻腔内薬物送達技術の種類別販売量 ・欧州の鼻腔内薬物送達技術の用途別販売量 ・ドイツの鼻腔内薬物送達技術市場 ・フランスの鼻腔内薬物送達技術市場 ・イギリスの鼻腔内薬物送達技術市場 ・イタリアの鼻腔内薬物送達技術市場 ・ロシアの鼻腔内薬物送達技術市場 中東・アフリカ市場 ・中東・アフリカの国別の鼻腔内薬物送達技術販売量、売上（2017-2022） ・中東・アフリカの鼻腔内薬物送達技術の種類別販売量 ・中東・アフリカの鼻腔内薬物送達技術の用途別販売量 ・エジプトの鼻腔内薬物送達技術市場 ・南アフリカの鼻腔内薬物送達技術市場 ・イスラエルの鼻腔内薬物送達技術市場 ・トルコの鼻腔内薬物送達技術市場 ・GCC諸国の鼻腔内薬物送達技術市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・鼻腔内薬物送達技術の製造コスト構造分析 ・鼻腔内薬物送達技術の製造プロセス分析 ・鼻腔内薬物送達技術の産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・鼻腔内薬物送達技術の主要なグローバル販売業者 ・鼻腔内薬物送達技術の主要なグローバル顧客 地域別の鼻腔内薬物送達技術市場予測レビュー ・地域別の鼻腔内薬物送達技術市場規模予測（2023-2028） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・鼻腔内薬物送達技術のタイプ別市場規模予測 ・鼻腔内薬物送達技術の用途別市場規模予測 主要企業分析 3M United States、 Aegis Therapeutics LLC、 Aptargroup, Inc.、 Becton, Dickinson and Company、 BF Ascher & Company, Inc.、 Cadila Pharmaceuticals Ltd、 Dickinson and Company、 Douglas Pharmaceuticals Ltd、 ENT Technologies Pty. Ltd、 Glaxosmithkline PLC、 Johnson & Johnson、 Merck & Co., Inc.、 Novartis AG、 OptiNose, Inc、 PendoPharm, Inc、 Pfizer, ・企業情報 ・鼻腔内薬物送達技術製品 ・鼻腔内薬物送達技術販売量、売上、価格、粗利益（2020-2022） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
As the global economy mends, the 2021 growth of Nasal Drug Delivery Technology will have significant change from previous year. According to our (LP Information) latest study, the global Nasal Drug Delivery Technology market size is USD million in 2022 from USD 53350 million in 2021, with a change of % between 2021 and 2022. The global Nasal Drug Delivery Technology market size will reach USD 73210 million in 2028, growing at a CAGR of 4.6% over the analysis period.
The United States Nasal Drug Delivery Technology market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nasal Drug Delivery Technology market, reaching US$ million by the year 2028. As for the Europe Nasal Drug Delivery Technology landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Nasal Drug Delivery Technology players cover 3M United States, Aegis Therapeutics LLC, Aptargroup, Inc., and Becton, Dickinson and Company, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Nasal Drug Delivery Technology market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Pressurized Type
Non-pressurized Type
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Nasal Congestion
Rhinitis
Asthma
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
3M United States
Aegis Therapeutics LLC
Aptargroup, Inc.
Becton, Dickinson and Company
BF Ascher & Company, Inc.
Cadila Pharmaceuticals Ltd
Dickinson and Company
Douglas Pharmaceuticals Ltd
ENT Technologies Pty. Ltd
Glaxosmithkline PLC
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
OptiNose, Inc
PendoPharm, Inc
Pfizer, Inc
Promius Pharma, LLC
Shin Nippon Biomedical Laboratories
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nasal Drug Delivery Technology Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Nasal Drug Delivery Technology by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Nasal Drug Delivery Technology by Country/Region, 2017, 2022 & 2028
2.2 Nasal Drug Delivery Technology Segment by Type
2.2.1 Pressurized Type
2.2.2 Non-pressurized Type
2.3 Nasal Drug Delivery Technology Sales by Type
2.3.1 Global Nasal Drug Delivery Technology Sales Market Share by Type (2017-2022)
2.3.2 Global Nasal Drug Delivery Technology Revenue and Market Share by Type (2017-2022)
2.3.3 Global Nasal Drug Delivery Technology Sale Price by Type (2017-2022)
2.4 Nasal Drug Delivery Technology Segment by Application
2.4.1 Nasal Congestion
2.4.2 Rhinitis
2.4.3 Asthma
2.4.4 Other
2.5 Nasal Drug Delivery Technology Sales by Application
2.5.1 Global Nasal Drug Delivery Technology Sale Market Share by Application (2017-2022)
2.5.2 Global Nasal Drug Delivery Technology Revenue and Market Share by Application (2017-2022)
2.5.3 Global Nasal Drug Delivery Technology Sale Price by Application (2017-2022)
3 Global Nasal Drug Delivery Technology by Company
3.1 Global Nasal Drug Delivery Technology Breakdown Data by Company
3.1.1 Global Nasal Drug Delivery Technology Annual Sales by Company (2020-2022)
3.1.2 Global Nasal Drug Delivery Technology Sales Market Share by Company (2020-2022)
3.2 Global Nasal Drug Delivery Technology Annual Revenue by Company (2020-2022)
3.2.1 Global Nasal Drug Delivery Technology Revenue by Company (2020-2022)
3.2.2 Global Nasal Drug Delivery Technology Revenue Market Share by Company (2020-2022)
3.3 Global Nasal Drug Delivery Technology Sale Price by Company
3.4 Key Manufacturers Nasal Drug Delivery Technology Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nasal Drug Delivery Technology Product Location Distribution
3.4.2 Players Nasal Drug Delivery Technology Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nasal Drug Delivery Technology by Geographic Region
4.1 World Historic Nasal Drug Delivery Technology Market Size by Geographic Region (2017-2022)
4.1.1 Global Nasal Drug Delivery Technology Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Nasal Drug Delivery Technology Annual Revenue by Geographic Region
4.2 World Historic Nasal Drug Delivery Technology Market Size by Country/Region (2017-2022)
4.2.1 Global Nasal Drug Delivery Technology Annual Sales by Country/Region (2017-2022)
4.2.2 Global Nasal Drug Delivery Technology Annual Revenue by Country/Region
4.3 Americas Nasal Drug Delivery Technology Sales Growth
4.4 APAC Nasal Drug Delivery Technology Sales Growth
4.5 Europe Nasal Drug Delivery Technology Sales Growth
4.6 Middle East & Africa Nasal Drug Delivery Technology Sales Growth
5 Americas
5.1 Americas Nasal Drug Delivery Technology Sales by Country
5.1.1 Americas Nasal Drug Delivery Technology Sales by Country (2017-2022)
5.1.2 Americas Nasal Drug Delivery Technology Revenue by Country (2017-2022)
5.2 Americas Nasal Drug Delivery Technology Sales by Type
5.3 Americas Nasal Drug Delivery Technology Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nasal Drug Delivery Technology Sales by Region
6.1.1 APAC Nasal Drug Delivery Technology Sales by Region (2017-2022)
6.1.2 APAC Nasal Drug Delivery Technology Revenue by Region (2017-2022)
6.2 APAC Nasal Drug Delivery Technology Sales by Type
6.3 APAC Nasal Drug Delivery Technology Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nasal Drug Delivery Technology by Country
7.1.1 Europe Nasal Drug Delivery Technology Sales by Country (2017-2022)
7.1.2 Europe Nasal Drug Delivery Technology Revenue by Country (2017-2022)
7.2 Europe Nasal Drug Delivery Technology Sales by Type
7.3 Europe Nasal Drug Delivery Technology Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nasal Drug Delivery Technology by Country
8.1.1 Middle East & Africa Nasal Drug Delivery Technology Sales by Country (2017-2022)
8.1.2 Middle East & Africa Nasal Drug Delivery Technology Revenue by Country (2017-2022)
8.2 Middle East & Africa Nasal Drug Delivery Technology Sales by Type
8.3 Middle East & Africa Nasal Drug Delivery Technology Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nasal Drug Delivery Technology
10.3 Manufacturing Process Analysis of Nasal Drug Delivery Technology
10.4 Industry Chain Structure of Nasal Drug Delivery Technology
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nasal Drug Delivery Technology Distributors
11.3 Nasal Drug Delivery Technology Customer
12 World Forecast Review for Nasal Drug Delivery Technology by Geographic Region
12.1 Global Nasal Drug Delivery Technology Market Size Forecast by Region
12.1.1 Global Nasal Drug Delivery Technology Forecast by Region (2023-2028)
12.1.2 Global Nasal Drug Delivery Technology Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nasal Drug Delivery Technology Forecast by Type
12.7 Global Nasal Drug Delivery Technology Forecast by Application
13 Key Players Analysis
13.1 3M United States
13.1.1 3M United States Company Information
13.1.2 3M United States Nasal Drug Delivery Technology Product Offered
13.1.3 3M United States Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 3M United States Main Business Overview
13.1.5 3M United States Latest Developments
13.2 Aegis Therapeutics LLC
13.2.1 Aegis Therapeutics LLC Company Information
13.2.2 Aegis Therapeutics LLC Nasal Drug Delivery Technology Product Offered
13.2.3 Aegis Therapeutics LLC Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Aegis Therapeutics LLC Main Business Overview
13.2.5 Aegis Therapeutics LLC Latest Developments
13.3 Aptargroup, Inc.
13.3.1 Aptargroup, Inc. Company Information
13.3.2 Aptargroup, Inc. Nasal Drug Delivery Technology Product Offered
13.3.3 Aptargroup, Inc. Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Aptargroup, Inc. Main Business Overview
13.3.5 Aptargroup, Inc. Latest Developments
13.4 Becton, Dickinson and Company
13.4.1 Becton, Dickinson and Company Company Information
13.4.2 Becton, Dickinson and Company Nasal Drug Delivery Technology Product Offered
13.4.3 Becton, Dickinson and Company Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Becton, Dickinson and Company Main Business Overview
13.4.5 Becton, Dickinson and Company Latest Developments
13.5 BF Ascher & Company, Inc.
13.5.1 BF Ascher & Company, Inc. Company Information
13.5.2 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Product Offered
13.5.3 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 BF Ascher & Company, Inc. Main Business Overview
13.5.5 BF Ascher & Company, Inc. Latest Developments
13.6 Cadila Pharmaceuticals Ltd
13.6.1 Cadila Pharmaceuticals Ltd Company Information
13.6.2 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Offered
13.6.3 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Cadila Pharmaceuticals Ltd Main Business Overview
13.6.5 Cadila Pharmaceuticals Ltd Latest Developments
13.7 Dickinson and Company
13.7.1 Dickinson and Company Company Information
13.7.2 Dickinson and Company Nasal Drug Delivery Technology Product Offered
13.7.3 Dickinson and Company Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Dickinson and Company Main Business Overview
13.7.5 Dickinson and Company Latest Developments
13.8 Douglas Pharmaceuticals Ltd
13.8.1 Douglas Pharmaceuticals Ltd Company Information
13.8.2 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Offered
13.8.3 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Douglas Pharmaceuticals Ltd Main Business Overview
13.8.5 Douglas Pharmaceuticals Ltd Latest Developments
13.9 ENT Technologies Pty. Ltd
13.9.1 ENT Technologies Pty. Ltd Company Information
13.9.2 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Product Offered
13.9.3 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 ENT Technologies Pty. Ltd Main Business Overview
13.9.5 ENT Technologies Pty. Ltd Latest Developments
13.10 Glaxosmithkline PLC
13.10.1 Glaxosmithkline PLC Company Information
13.10.2 Glaxosmithkline PLC Nasal Drug Delivery Technology Product Offered
13.10.3 Glaxosmithkline PLC Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Glaxosmithkline PLC Main Business Overview
13.10.5 Glaxosmithkline PLC Latest Developments
13.11 Johnson & Johnson
13.11.1 Johnson & Johnson Company Information
13.11.2 Johnson & Johnson Nasal Drug Delivery Technology Product Offered
13.11.3 Johnson & Johnson Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Johnson & Johnson Main Business Overview
13.11.5 Johnson & Johnson Latest Developments
13.12 Merck & Co., Inc.
13.12.1 Merck & Co., Inc. Company Information
13.12.2 Merck & Co., Inc. Nasal Drug Delivery Technology Product Offered
13.12.3 Merck & Co., Inc. Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Merck & Co., Inc. Main Business Overview
13.12.5 Merck & Co., Inc. Latest Developments
13.13 Novartis AG
13.13.1 Novartis AG Company Information
13.13.2 Novartis AG Nasal Drug Delivery Technology Product Offered
13.13.3 Novartis AG Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Novartis AG Main Business Overview
13.13.5 Novartis AG Latest Developments
13.14 OptiNose, Inc
13.14.1 OptiNose, Inc Company Information
13.14.2 OptiNose, Inc Nasal Drug Delivery Technology Product Offered
13.14.3 OptiNose, Inc Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 OptiNose, Inc Main Business Overview
13.14.5 OptiNose, Inc Latest Developments
13.15 PendoPharm, Inc
13.15.1 PendoPharm, Inc Company Information
13.15.2 PendoPharm, Inc Nasal Drug Delivery Technology Product Offered
13.15.3 PendoPharm, Inc Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 PendoPharm, Inc Main Business Overview
13.15.5 PendoPharm, Inc Latest Developments
13.16 Pfizer, Inc
13.16.1 Pfizer, Inc Company Information
13.16.2 Pfizer, Inc Nasal Drug Delivery Technology Product Offered
13.16.3 Pfizer, Inc Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Pfizer, Inc Main Business Overview
13.16.5 Pfizer, Inc Latest Developments
13.17 Promius Pharma, LLC
13.17.1 Promius Pharma, LLC Company Information
13.17.2 Promius Pharma, LLC Nasal Drug Delivery Technology Product Offered
13.17.3 Promius Pharma, LLC Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Promius Pharma, LLC Main Business Overview
13.17.5 Promius Pharma, LLC Latest Developments
13.18 Shin Nippon Biomedical Laboratories
13.18.1 Shin Nippon Biomedical Laboratories Company Information
13.18.2 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Product Offered
13.18.3 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Shin Nippon Biomedical Laboratories Main Business Overview
13.18.5 Shin Nippon Biomedical Laboratories Latest Developments
14 Research Findings and Conclusion